Tenax Therapeutics (NASDAQ:TENX) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Tenax Therapeutics Trading Down 1.2 % TENX opened at $3.32 on Tuesday. Tenax Therapeutics has a 52-week low of $2.77 and a 52-week […]

Leave a Reply

Your email address will not be published.

Previous post Franks: Trump’s trajectory rankles angry Democrats
Next post T-Mobile US (NASDAQ:TMUS) Stock Rating Lowered by StockNews.com